Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Li-Fraumeni syndrome (LFS) is a hereditary condition which is often associated with a pathogenic or likely pathogenic variant (mutation) in the TP53 gene (TP53 positive genetic test result or TP53+ result). If your patient has a family history of multiple people on the same side of the family diagnosed with LFS cancers, especially at young ages, please refer the patient to our Li-Fraumeni Syndrome and TP53 Center.
We recommend our services to people who:
A patient's primary care physician or community specialist is an integral part of the patient's care team. We are committed to working with you in the long-term care of your patient with Li-Fraumeni syndrome and TP53+ results.
Find out more about how to refer a patient to our Center. Note: When selecting the "Diagnosis," choose the "Cancer Genetics and Prevention (Adult)" option.
For genetic counselors following patients with Li-Fraumeni syndrome and TP53+ results, please contact us to ensure your patients are receiving the most up-to-date
and optimal care.